Contact information
Research groups
Colleges
Hussein Al-Mossawi
BMBCh MRCP DPhil
Honorary Research Associate
- Fellow and Lecturer, St Edmund Hall
Hussein Al-Mossawi completed his medical degree at Trinity College Oxford in 2006. He went on to complete his foundation and core medical training at the Oxford Deanery and moved to Bristol in 2010 to start specialist training in Rheumatology.
He returned to Oxford in 2012 to commence translational immunology research supervised by Paul Bowness and Fiona Powrie and funded by a Wellcome trust clinical fellowship. He completed his DPhil studies in 2016 and worked on pathological immune responses in Spondyloarthritis with a particular focus on the role of GM-CSF in axial and peripheral spondyloarthritis and the role of IL7R polymorphisms in inflammation.
He is currently an honorary research associate at NDORMS and his current work focuses on the immunobiology of Psoriatic Arthritis. Additionally he is a fellow and lecturer in pathology and immunology at St Edmund Hall.
Key publications
-
Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis.
Al-Mossawi MH. et al, (2017), Nat commun, 8
Recent publications
-
Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL17 treatment: a clinical case.
James L. et al, (2025), Rheumatology (oxford)
-
Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL17 treatment: a clinical case
James L. et al, (2025), Rheumatology
-
Genetic determinants of monocyte splicing are enriched for disease susceptibility loci including for COVID-19
Fairfax B. et al, (2024)
-
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.
Worth C. et al, (2024), Lancet rheumatol
-
A first in disease phase 2, randomised, controlled trial of Granulocyte-Macrophage Colony-Stimulating factor neutralisation for Axial Spondyloarthritis (NAMASTE study)
Jones C. et al, (2024), Lancet rheumatology